Cell-based calcification assays - magnesium overrules calcium phosphate saturation in overall outcome1

Area of Science:

• Biochemistry
• Mineral Metabolism
• Cardiovascular Health

Background:

• Soft tissue calcification contributes to cardiovascular mortality, particularly in chronic kidney disease (CKD).
• The precise role of magnesium (Mg) in calcification, especially its extracellular mechanisms, is not fully understood.
• Understanding Mg's influence is crucial for managing calcification-related diseases.

Purpose of the Study:

• To investigate the extracellular mechanisms by which magnesium (Mg) influences soft tissue calcification.
• To elucidate the dual role of Mg in stabilizing or inhibiting mineral precipitation in calcification media.

Main Methods:

• Utilized fluorescence-labeled fetuin-A and live imaging to observe mineral precipitation.
• Employed dynamic light scattering to analyze colloidal protein-mineral particles (CPP).
• Tested varying concentrations of calcium, phosphate, and Mg in in vitro calcification media.

Main Results:

• Mg at 1.25-5 mM stabilized colloidal protein-mineral particles (CPP), increasing calcification.
• Lower Mg concentrations (up to 4 mM) resulted in smaller, more numerous CPP.
• High Mg concentration (10 mM) inhibited calcification, even with high calcium and phosphate levels.

Conclusions:

• Magnesium exhibits a dual role in calcification: it facilitates mineral availability from CPP at moderate concentrations (up to ~5 mM) but inhibits aggregation at higher concentrations.
• Mg stabilizes mineral precursors, influencing the dynamics of matrix calcification.
• Findings highlight a critical Mg concentration range affecting soft tissue calcification and cardiovascular risk.